Search

everythinglearnresearchcommunity

for

Search:↓

Higher levels of IL-17A and IL-2 are linked to alopecia areata.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Finasteride works best in 6 months and lasts 6 years.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

CD34-positive cells help repair and form new blood vessels in salivary glands after radiation.

Genomic approach finds new possible treatments for hair loss.

Hyaluronic acid fillers and combination treatments significantly improve facial defects from autoimmune diseases and are well-tolerated.

PRP injections may slightly improve hair density and count for male hair loss, but more research is needed.

Celery extract and candlenut oil effectively and safely boost hair growth.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

SL-HyDE improves medical information retrieval accuracy without needing labeled data.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

Rutin may protect against stomach damage caused by sodium valproate.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

FDG PET/CT can improve cancer treatment plans in dogs.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Using SVF enriched with PRP in surgery for certain fistulas is effective and safe.

Combining plasma rich in growth factors with hair transplant surgery may lead to faster recovery and better outcomes for hair loss treatment.

PRP therapy for alopecia shows inconsistent results due to natural variability in growth factor secretion by platelets.

Hairless mice are more vulnerable to Listeria infection, but gut microbiota can help reduce damage.

Taking finasteride before surgery reduces blood loss in prostate procedures.

Hair follicle stem cells are similar to mesenchymal stem cells and can become neural-like cells under certain conditions.

Methimazole can cause severe low platelet count in Graves' disease patients, so monitoring and alternative treatments are important.

Neutropenic patients show significant changes in immune cell types and lower neutrophil and natural killer cell percentages.

Androgenetic alopecia is a long-term, immune-related disorder that starts during puberty due to androgen secretion, and it might be improved with iron tablets, platelet transfusion, and anti-inflammation therapy.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.